S. 4355 Introduced Health

Drug Deal Disclosure Act

A bill to require the Department of Health and Human Services to release documents, communications, and other information relating to most favored nation pricing agreements and other private or confidential drug pricing deals struck with manufacturers, and for other purposes.

  1. Introduced
  2. Committee
  3. Passed Senate
  4. Passed House
  5. To President
  6. Became law
Sponsor Sen. Wyden, Ron [D-OR] Introduced April 21, 2026 Cosponsors 18 (17 D, 1 I) Latest action April 21, 2026

Summary

The Congressional Research Service has not published a summary of this bill yet.

Congress.gov

Actions

  1. Apr 21, 2026 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  2. Apr 21, 2026 Introduced in Senate

Congressional and federal records come from official public sources: the House Clerk, the U.S. Senate, GovInfo and the Library of Congress (bill status), the Federal Register, and the congress-legislators project. They are copied on a schedule and may lag the official record by a few hours; the official sources govern. News and coverage counts are drawn from the 4Conservative index and reflect what the press published, not 4Conservative's views. Nothing here is an endorsement of any candidate, party or position. Terms of use.